BSE Live
Nov 13, 16:01Prev. Close
9287.15
Open Price
9288.95
Bid Price (Qty.)
9000.00 (2)
Offer Price (Qty.)
9204.10 (100)
NSE Live
Nov 13, 15:54Prev. Close
9282.00
Open Price
9330.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
9183.00 (138)
| Cash Flow of AstraZeneca Pharma (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 15 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | -20.84 | 0.00 | -70.27 | 29.25 | 100.95 | |
| Net CashFlow From Operating Activities | -45.70 | -0.81 | -6.04 | 37.73 | 64.50 | |
| Net Cash Used In Investing Activities | -18.64 | -14.57 | -15.62 | -32.68 | -27.69 | |
| Net Cash Used From Financing Activities | 0.00 | 86.22 | -10.33 | -29.07 | -29.09 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -64.34 | 70.84 | -31.98 | -24.03 | 7.72 | |
| Cash And Cash Equivalents Begin of Year | 87.68 | 16.83 | 48.81 | 72.84 | 65.12 | |
| Cash And Cash Equivalents End Of Year | 23.33 | 87.68 | 16.83 | 48.81 | 72.84 |
12.11.2025
AstraZeneca Standalone September 2025 Net Sales at Rs 559.09 crore, up 37.03% Y-o-Y
10.11.2025
31.07.2025
06.06.2025
AstraZeneca Standalone March 2025 Net Sales at Rs 480.48 crore, up 25.39% Y-o-Y
12.11.2025
AstraZeneca Standalone September 2025 Net Sales at Rs 559.09 crore, up 37.03% Y-o-Y
06.06.2025
AstraZeneca Standalone March 2025 Net Sales at Rs 480.48 crore, up 25.39% Y-o-Y
17.02.2025
AstraZeneca Standalone December 2024 Net Sales at Rs 440.29 crore, up 43.98% Y-o-Y
21.11.2024
AstraZeneca Standalone September 2024 Net Sales at Rs 408.00 crore, up 31.16% Y-o-Y